Granulomatosis With Polyangiitis Clinical Trials

46 clinical trials for Granulomatosis With Polyangiitis across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases — RECRUITING · PHASE4
• Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis — RECRUITING · PHASE3
• Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis — RECRUITING · PHASE2
• Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW) — RECRUITING · PHASE3
• Vasculitis Pregnancy Registry — RECRUITING
• One-Time DNA Study for Vasculitis — RECRUITING
• Clinical Transcriptomics in Systemic Vasculitis (CUTIS) — RECRUITING
• VCRC Tissue Repository — RECRUITING
• SAFE EFFECTIVE THERAPY WITH LOW-DOSE GLUCOCORTICOID IN ANCA-ASSOCIATED VASCULITIS (SAFE-LOW) TRIAL — RECRUITING
• Special Drug Use-results Survey for Long-term Use（Avacopan） — RECRUITING
• Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. — RECRUITING · PHASE1
• A RANDOMIZED, CONTROLLED STUDY TO EVALUATE LNP023 (IPTACOPAN) IN PATIENTS WITH ACTIVE ANCA-ASSOCIATED VASCULITIS — RECRUITING
• A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF NS-229 IN THE TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS — RECRUITING · PHASE2
• The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach — COMPLETED · PHASE3
• Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3 — COMPLETED
• TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis — NOT_YET_RECRUITING · PHASE2
• PR3-AAV Resilient Remission or PRRR — TERMINATED · PHASE2
• Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis — COMPLETED · PHASE2
• Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator — COMPLETED
• TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis — ACTIVE_NOT_RECRUITING · PHASE1
• Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) — COMPLETED
• Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis — COMPLETED · PHASE3
• A PHASE 2, RANDOMIZED, OPEN-LABEL, CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RAPCABTAGENE AUTOLEUCEL VERSUS COMPARATOR IN PARTICIPANTS WITH SEVERE ACTIVE GRANULOMATOSIS WITH POLYANGIITIS (GPA) OR MICROSCOPIC POLYANGIITIS (MPA) — NOT_YET_RECRUITING · PHASE2
• The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach — OTHER · PHASE3
• Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) — COMPLETED · PHASE3
• Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia. — COMPLETED
• PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis — COMPLETED · NA
• Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis. — COMPLETED · PHASE2
• Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis — COMPLETED
• Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA — TERMINATED · PHASE2
• Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers — OTHER · PHASE1
• Rituximab and Belimumab Combination Therapy in PR3 Vasculitis — OTHER · PHASE2
• Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA — OTHER · PHASE4
• Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis — COMPLETED · PHASE4
• Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 Study — WITHDRAWN
• Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD) — OTHER
• A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis — COMPLETED · PHASE2
• Yellow Fever Vaccine in Patients With Rheumatic Diseases — COMPLETED · NA
• Cardiovascular Involvement in Patients With Granulomatosis With Polyangiitis — OTHER
• An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis — COMPLETED
• Journey of Patients With Vasculitis From First Symptom to Diagnosis — COMPLETED
• Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis — TERMINATED · PHASE4
• Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study — TERMINATED
• BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis — WITHDRAWN · PHASE2
• Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis — OTHER
• Alemtuzumab for ANCA Associated Refractory Vasculitis — OTHER · PHASE4

Refine this search